Lyra Therapeutics, Inc. - LYRA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Jan 20, 2026 | SCHEDULE 13G | SABBY MANAGEMENT, LLC | 9.9% | 175,158 | View |
| Jan 20, 2026 | SCHEDULE 13G | Hal Mintz | 9.9% | 175,158 | View |
| Jan 20, 2026 | SCHEDULE 13G | Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 175,158 | View |
| Nov 25, 2025 | SCHEDULE 13D/A | — | 5.0% | — | View |
| Nov 18, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 13, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Nov 10, 2025 | SCHEDULE 13D/A | — | — | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.